Bon Natural Life Limited
Bon Natural Life Limited (BON) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Bon Natural Life Limited (BON), featuring income statements, balance sheets, and cash flow data.
Bon Natural Life Limited (BON) Income Statement & Financial Overview
Explore comprehensive income reports for Bon Natural Life Limited BON, broken down by year and quarter.
Metric | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $10.18M | $7.69M | $7.69M | $14.15M |
Cost of Revenue | $7.22M | $5.62M | $5.62M | $9.43M |
Gross Profit | $2.97M | $2.06M | $2.06M | $4.72M |
Gross Profit Ratio | $0.29 | $0.27 | $0.27 | $0.33 |
R&D Expenses | $890384.00 | $84237.00 | $84237.00 | $129995.00 |
SG&A Expenses | $1.99M | $510399.00 | $510399.00 | $1.60M |
Operating Expenses | $2.88M | $594636.00 | $560727.00 | $1.73M |
Total Costs & Expenses | $10.10M | $6.22M | $6.19M | $11.16M |
Interest Income | $0.00 | $687.00 | $29490.00 | $8732.00 |
Interest Expense | $0.00 | $59667.00 | $0.00 | $178557.00 |
Depreciation & Amortization | $686038.00 | $335815.00 | $335815.00 | $397067.00 |
EBITDA | $770544.00 | $1.80M | $1.80M | $3.19M |
EBITDA Ratio | $0.08 | $0.23 | $0.23 | $0.24 |
Operating Income | $84506.00 | $1.47M | $1.47M | $2.99M |
Operating Income Ratio | $0.008 | $0.19 | $0.19 | $0.21 |
Other Income/Expenses (Net) | -$35570.00 | $4419.00 | $4419.00 | -$372501.00 |
Income Before Tax | $48936.00 | $1.47M | $1.47M | $2.61M |
Income Before Tax Ratio | $0.005 | $0.19 | $0.19 | $0.18 |
Income Tax Expense | $90734.00 | $246110.00 | $246110.00 | $510077.00 |
Net Income | -$10520.00 | $1.24M | $1.24M | $2.12M |
Net Income Ratio | -$0.001 | $0.16 | $0.16 | $0.15 |
EPS | -$0.008 | $1.32 | $1.32 | $1.19 |
Diluted EPS | -$0.008 | $1.30 | $1.30 | $1.19 |
Weighted Avg Shares Outstanding | $1.29M | $954098.00 | $954098.00 | $891831.00 |
Weighted Avg Shares Outstanding (Diluted) | $1.29M | $941698.00 | $941698.00 | $897924.00 |
Over the past four quarters, Bon Natural Life Limited demonstrated steady revenue growth, increasing from $14.15M in Q2 2023 to $10.18M in Q2 2024. Operating income reached $84506.00 in Q2 2024, maintaining a consistent 1% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $770544.00, reflecting operational efficiency. Net income dropped to -$10520.00, with EPS at -$0.008. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan